FDA Publishes Proposed Rule on Sections 503A and 503B Compounding | McDermott Will & Emery
On March 20, 2024, the US Food & Drug Administration (FDA) issued a proposed rule titled Drug Products or Categories of Drug Products that Present Demonstrable Difficulties for...
National Association Of Boards Pharmacy Federation Of State Medical Boards Us Food Drug Administration Pharmacy Compounding Advisory Committee Human Services Mcdermott Will
Source: jdsupra.com